保肝消脂冲剂治疗非酒精性脂肪肝（气滞湿阻证）的临床研究

目的观察保肝消脂冲剂治疗非酒精性脂肪肝患者的临床疗效。方法将符合入选标准病例随机分为治疗组和对照组,其中治疗组35例,服用保肝消脂冲剂,每日一剂,分两次温服;对照组30例,服用东宝肝泰片,每次3片,每日3次;两组均2个月为一疗程,均服用一个疗程,观察两组患者治疗前后血清γ-GT、ALT、AST水平、临床症状与体征的变化。结果治疗组较对照组症状和体征积分下降均具有显著性差异（P〈0.05）,治疗组γ-GT、ALT、AST下降较对照组明显（P〈0.05）。结论保肝消脂冲剂治疗非酒精性脂肪肝在降低γ-GT、ALT、AST,减轻临床症状、体征等方面,均明显优于对照组。

Clinical Study of Baoganxiaozhi Buffer on Non-alcohol Fatty Liver of Qi Stagnation and Water Retention

Objective To observe the effect of Baoganxiaozhi Buffer of Non-alcohol fatty liver.Methods Case in accordance with the standard random number table to take control methods,divided into two groups,treatment group was 35 cases,Baoganxiaozhi Buffer was taken for 2 months.Control group was 30 cases,Dongbaogantai was taken for 2 months.Observe of the treatment group and control group before and after treatment serum liver function(γ-GT,ALT,AST),clinical symptoms and signs of change.Results the two groups after treatment Syndrome total score,the signs and symptoms of integral points than before treatment were significantly lower (P<0.05),and the treatment group improved significantly.The two groups before and after treatment γ-GT,ALT,AST was significantly lower than the control group there were significant differences (P<0.05).Conclusion Baoganxiaozhi Buffer can significantly reduce patients with clinical symptoms and debase liver function(γ-GT,ALT,AST).